This material is for information purposes and does not constitute legal advice that is tailored to your own personal circumstances and should not replace legal advice of an attorney. Although we try our best to keep the information updated, the material is not guaranteed to be up to date or complete.
Rare Cancer Agenda 2030 - Paperback
by Rare Cancers Europe (Author)
RARE CANCER AGENDA 2030 Ten Recommendations from the EU Joint Action on Rare Cancers 1. Rare cancers are the rare diseases of oncology 2. Rare cancers should be monitored 3. Health systems should exploit networking 4. Medical education should exploit and serve healthcare networking 5. Research should be fostered by networking and should take into account an expected higher degree of uncertainty 6. Patient-physician shared clinical decision-making should be especially valued 7. Appropriate state-of-the-art instruments should be developed in rare cancer 8. Regulation on rare cancers should tolerate a higher degree of uncertainty 9. Policy strategies on rare cancers and sustainability of interventions should be based on networking 10. Rare cancer patients should be engaged